Research demonstrates effective bispecific targeting of cell receptors using DNA-peptide probes, highlighting their potential in diagnostics and therapeutics.
Key Points
The bispecific DNA-peptide probes enable targeted internalization into cells, enhancing therapeutic delivery and specificity.
Spatial screening identified an optimal distance of over 20 nucleotides to ensure precise receptor targeting in HUVECs.
This approach contrasts with standard agents by using low molecular weight DNA nanostructures instead of larger antibodies.
Targeting enhances the delivery of cytotoxic payloads like Auristatin selectively to desired cells.